|Mr. Michael C. Kavanagh M.B.A., BSc||CEO, Pres, MD & Exec. Director||814.52k||N/A||N/A|
|Mr. McGregor Grant C.A., FCIS, BEc, CA, GAICD||CFO & Company Sec.||394.69k||N/A||N/A|
|Mr. Rod Lopez M.B.A.||Chief Operating Officer||374.87k||N/A||N/A|
|Dr. Steven Farrugia BE, Ph.D.||Chief Technology Officer||374k||N/A||N/A|
|Mr. David N. Morris||Chief Strategy Officer & Regional Pres Asia Pacific||435.56k||N/A||N/A|
|Ms. Renee Salaberry M.B.A.||Chief Marketing Officer||N/A||N/A||N/A|
|Ms. Jodi Sampson||Chief People & Culture Officer||N/A||N/A||N/A|
|Mr. Vincent Wang||Head of Global Customer Support & Technical Services||N/A||N/A||N/A|
|Mr. Keith Koby||Sr. VP of Sales - North America||N/A||N/A||N/A|
|Mr. Ken Shaw||Regional Pres of United States, Canada & Latin America||N/A||N/A||N/A|
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. The company offers its products primarily to sonographers, hospitals, obstetricians, and gynecologists. Nanosonics Limited was incorporated in 2000 and is headquartered in Lane Cove, Australia.
Nanosonics Limited’s ISS Governance QualityScore as of September 26, 2021 is 6. The pillar scores are Audit: 3; Board: 5; Shareholder Rights: 10; Compensation: 2.